Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
JY231 Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
B-cell Malignancies
1 trial -
Jelly confectionary Snakes
United Therapeutics Europe Ltd
POSTOP NAUSEA VOMITING
1 trial -
Jianpixiaozhong particles and Wuse Dietotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Idiopathic Membranous Nephropathy
1 trial -
KL003 Cell Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sickle Cell Disease
1 trial -
KL003 cell injection Drug Product
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Transfusion-dependent Beta-Thalassemia
1 trial -
Kava (Piper methysticum) extract
The First People's Hospital of Lianyungang
Sleep
1 trial -
Kefir peptide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Obesity
1 trial -
Ketamine
The First People's Hospital of Lianyungang
Intensive Care Unit
1 trial -
Ketogenic Diet
United Therapeutics Europe Ltd
CNS Oxygen Toxicity, Ketogenic Diet
1 trial -
Ketogenic diet
United Therapeutics Europe Ltd
Heart Failure With Preserved Ejection Fraction
1 trial -
Ketogenic diet
Hospital Authority, Hong Kong
Drug Resistant Epilepsy
1 trial -
Ketogenic food products
United Therapeutics Europe Ltd
Oxygen Toxicity
2 trials -
Ketone ester
United Therapeutics Europe Ltd
Ketosis
1 trial -
Ketone ester
COGNITION THERAPEUTICS INC
Hypoxia
2 trials -
Kunxian capsule
The First People's Hospital of Lianyungang
Diabetic Nephropathy
1 trial -
Kuvan
BioMarin Pharmaceutical Australia Pty Ltd
Heart Failure
1 trial -
L-Carnitine tartrate
United Therapeutics Europe Ltd
Non-Alcoholic Fatty Liver Disease
1 trial -
LCAR- F33S cells intravenous infusion
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Relapsed/Refractory Multiple Myeloma(MM)
1 trial -
LCAR-M61S cells preparation
Nanjing Legend Biotech Co.
Relapsed/Refractory Multiple Myeloma
1 trial -
LCI+white light
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Early Gastric Cancer
1 trial -
LOC387715/HTRA1 genotyping
Hospital Authority, Hong Kong
Age-Related Macular Degeneration
1 trial -
Lactated ringers solution
The First People's Hospital of Lianyungang
Pancreatitis, Chronic
1 trial -
Lactobacillus rhamnosus F-1
Biotech Pharmaceutical Co.,
Allergic Rhinitis
1 trial -
Lactose-free milk formula (Frisolac LF ®)
Hospital Authority, Hong Kong
Acute Gastroenteritis
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources